Revelation Biosciences (REVB) News Today

$2.78

0.00 (0.00%)

(As of 02/9/2024 08:56 PM ET)

Source

Source	Headline
	Revelation Biosciences Secures $6.2M in Public Offering msn.com - February 9 at 5:28 PM
	Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering finance.yahoo.com - February 5 at 8:04 PM
	marketbeat.com - February 5 at 2:29 PM
	Revelation Biosciences Shares Slide Premarket on Public Offering marketwatch.com - February 2 at 12:49 AM
	Revelation Biosciences to raise ~$6.2M through public offering of shares msn.com - February 1 at 2:49 PM
	Why Is Revelation Biosciences (REVB) Stock Down 62% Today? investorplace.com - February 1 at 9:14 AM
	marketbeat.com - January 31 at 9:52 AM
	marketbeat.com - January 31 at 9:46 AM
	marketbeat.com - January 31 at 9:37 AM
	Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024) finance.yahoo.com - January 30 at 12:55 PM
	FATE, NEXI and INBS among mid-day movers seekingalpha.com - January 29 at 3:44 PM
	marketbeat.com - January 29 at 11:50 AM
	marketbeat.com - January 29 at 11:11 AM
	marketbeat.com - January 29 at 10:49 AM
	marketbeat.com - January 29 at 10:42 AM
	marketbeat.com - January 29 at 10:12 AM
	marketbeat.com - January 29 at 9:49 AM
	marketbeat.com - January 29 at 9:40 AM
	marketbeat.com - January 29 at 9:36 AM
	REVB Continues March to Trials finance.yahoo.com - January 26 at 6:25 PM
	marketbeat.com - January 25 at 6:11 AM
	Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024 finance.yahoo.com - January 23 at 11:15 AM
	Revelation Biosciences Inc Ordinary Shares REVB morningstar.com - November 22 at 2:02 PM
	REVB Releases Earnings and Prepares for Trials finance.yahoo.com - November 14 at 1:12 PM
	Revelation Biosciences GAAP EPS of -$0.42 msn.com - November 14 at 8:12 AM
	Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 finance.yahoo.com - November 13 at 5:39 PM
	Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies finance.yahoo.com - October 12 at 10:25 AM
	Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference finance.yahoo.com - October 4 at 1:12 PM
	Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors finance.yahoo.com - October 2 at 9:11 AM
	REVB Reports Solid Balance Sheet and Remains on Track finance.yahoo.com - August 14 at 4:02 PM
	Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023 finance.yahoo.com - August 11 at 5:39 PM
	REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders finance.yahoo.com - June 29 at 9:45 AM
	REVB: REVB Looks Attractive Ahead of Trials finance.yahoo.com - June 22 at 3:37 PM
	Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal finance.yahoo.com - June 12 at 7:09 PM
	REVB - Revelation Biosciences, Inc. finance.yahoo.com - June 6 at 4:09 PM
	Revelation Biosciences GAAP EPS of $1.96 seekingalpha.com - May 22 at 10:08 AM
	Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress finance.yahoo.com - May 22 at 10:08 AM
	Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress finance.yahoo.com - March 30 at 7:34 PM
	REVB Revelation Biosciences, Inc. seekingalpha.com - March 30 at 3:52 AM
	Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference finance.yahoo.com - March 6 at 11:03 AM
	Why Revelation Biosciences Is Trading 40% Lower Thursday msn.com - February 9 at 5:57 PM
	Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering finance.yahoo.com - February 9 at 12:57 PM
	Insiders who bought in the last 12 months lose an additional US$99k as Revelation Biosciences, Inc. (NASDAQ:REVB) drops to US$5.8m uk.news.yahoo.com - February 7 at 11:30 PM
	The Prophet Muhammad’s revelation bbc.co.uk - February 7 at 1:29 PM
	Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate msn.com - February 7 at 1:29 PM
	Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300 finance.yahoo.com - February 7 at 1:29 PM
	Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders finance.yahoo.com - January 31 at 4:47 PM
	Pat Cummins makes surprise David Warner revelation as veteran opener is named Player of the Series dailymail.co.uk - January 10 at 5:50 PM
	Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model finance.yahoo.com - November 18 at 12:31 PM
	Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress finance.yahoo.com - November 10 at 5:40 PM

Get Revelation Biosciences News Delivered to You Automatically

REVB Media Mentions By Week

REVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REVB
News Sentiment
▼
1.03

0.92
▲
Average
Medical
News Sentiment

REVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REVB Articles
This Week
▼
4

0
▲
REVB Articles
Average Week

Get Revelation Biosciences News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:REVB) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Revelation Biosciences (REVB) News Today

REVB Media Mentions By Week

REVB Media Sentiment

REVB News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info